EP3999070A4 - Brausetablettenzusammensetzung von sitagliptin - Google Patents

Brausetablettenzusammensetzung von sitagliptin Download PDF

Info

Publication number
EP3999070A4
EP3999070A4 EP20841192.6A EP20841192A EP3999070A4 EP 3999070 A4 EP3999070 A4 EP 3999070A4 EP 20841192 A EP20841192 A EP 20841192A EP 3999070 A4 EP3999070 A4 EP 3999070A4
Authority
EP
European Patent Office
Prior art keywords
sitagliptin
effervescent tablet
tablet composition
composition
effervescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20841192.6A
Other languages
English (en)
French (fr)
Other versions
EP3999070A1 (de
Inventor
Seval Ataman
Muge ULUSOY BOZYEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3999070A1 publication Critical patent/EP3999070A1/de
Publication of EP3999070A4 publication Critical patent/EP3999070A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
EP20841192.6A 2019-07-17 2020-07-10 Brausetablettenzusammensetzung von sitagliptin Pending EP3999070A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/10633A TR201910633A1 (tr) 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu
PCT/TR2020/050615 WO2021010924A1 (en) 2019-07-17 2020-07-10 An effervescent tablet composition of sitagliptin

Publications (2)

Publication Number Publication Date
EP3999070A1 EP3999070A1 (de) 2022-05-25
EP3999070A4 true EP3999070A4 (de) 2023-08-16

Family

ID=74209853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20841192.6A Pending EP3999070A4 (de) 2019-07-17 2020-07-10 Brausetablettenzusammensetzung von sitagliptin

Country Status (3)

Country Link
EP (1) EP3999070A4 (de)
TR (1) TR201910633A1 (de)
WO (1) WO2021010924A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116406666A (zh) * 2023-04-12 2023-07-11 国网福建省电力有限公司电力科学研究院 一种植物诱抗剂泡腾片及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (en) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Crystalline salts of sitagliptin
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077819A1 (en) * 2011-11-23 2013-05-30 Mahmut Bilgic Pharmaceutical formulations comprising nateglinide
WO2013115744A1 (en) * 2012-01-31 2013-08-08 Mahmut Bilgic A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (en) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Crystalline salts of sitagliptin
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021010924A1 *

Also Published As

Publication number Publication date
WO2021010924A1 (en) 2021-01-21
TR201910633A1 (tr) 2021-05-21
EP3999070A1 (de) 2022-05-25

Similar Documents

Publication Publication Date Title
EP3914252A4 (de) Pharmazeutische zusammensetzung von nilotinib
EP3849983A4 (de) Triazolpyrimidinverbindungen und verwendungen davon
EP3582777A4 (de) Pharmazeutische zusammensetzung aus apixaban
EP4082010A4 (de) Kombinieren von räumlichen audioparametern
EP3728260A4 (de) Exo-aza-spiro-hemmer der menin-mll-wechselwirkung
EP4125815A4 (de) Therapeutische zusammensetzungen
EP3630113A4 (de) Pharmazeutische zusammensetzung, pde9-inhibitor umfassend
EP3927729A4 (de) Therapeutische antikörperformulierung
EP3810118A4 (de) Formulierungen von tegavivint und verwandten verbindungen
EP3873444A4 (de) Therapeutische verbindungen und zusammensetzungen
EP3851121A4 (de) Pharmazeutische zusammensetzung mit menschlichen monoklonalen anti-il-33-antikörpern
EP3781135A4 (de) Feste orale pharmazeutische zusammensetzungen mit sitagliptin
EP3976001A4 (de) Tablettenformulierungen von apremilast
EP4077256A4 (de) Herstellung von halogeniertem alkoxyethan
EP3873446A4 (de) Therapeutische verbindungen und zusammensetzungen
EP3784672A4 (de) Tablettenformulierungen mit metformin und sitaglipitin
EP3755376A4 (de) Formulierungen mit mucin-beeinträchtigenden proteasen
EP3999070A4 (de) Brausetablettenzusammensetzung von sitagliptin
EP4081651A4 (de) Zusammensetzungen mit mir-335
EP3894418A4 (de) Herstellung von triiodosilanen
EP4077257A4 (de) Herstellung von halogeniertem alkoxyethan
EP3972598A4 (de) Neue verwendungen von crenolanib
EP3881841A4 (de) Pharmazeutische zusammensetzung
EP3801532A4 (de) Formulierungen von raltegravir
EP3749662A4 (de) Therapeutische verbindungen und zusammensetzungen

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230717

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/00 20060101ALI20230711BHEP

Ipc: A61K 9/20 20060101ALI20230711BHEP

Ipc: A61K 9/46 20060101ALI20230711BHEP

Ipc: A61K 31/4985 20060101AFI20230711BHEP